{"nctId":"NCT02279498","briefTitle":"SOLUTION: Study of Oral Liprotamase Unit-Matched Therapy Of Non-Porcine Origin in Patients With Cystic Fibrosis","startDateStruct":{"date":"2015-06","type":"ACTUAL"},"conditions":["Exocrine Pancreatic Insufficiency","Cystic Fibrosis"],"count":128,"armGroups":[{"label":"Liprotamase","type":"EXPERIMENTAL","interventionNames":["Drug: Liprotamase"]},{"label":"porcine (pig) PERT","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: porcine (pig) PERT"]}],"interventions":[{"name":"Liprotamase","otherNames":[]},{"name":"porcine (pig) PERT","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Diagnosis of Cystic Fibrosis based on presentation, genotype and/or sweat chloride\n* Fecal elastase \\<100 mcg/g stool\n* Minimum Coefficient of Fat (CFA) at screening while on stable PERT therapy\n* Good nutritional status\n\nExclusion Criteria:\n\n* History or diagnosis of fibrosing colonopathy\n* Distal intestinal obstruction syndrome in 6 months prior to screening\n* Receiving enteral tube feedings\n* Chronic diarrheal illness unrelated to pancreatic insufficiency\n* Liver abnormalities, or liver or lung transplant, or significant bowel resection\n* Forced expiratory volume in 1 second (FEV1) \\<30%","healthyVolunteers":false,"sex":"ALL","minimumAge":"7 Years","stdAges":["CHILD","ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Treatment Difference in Coefficient of Fat Absorption (CFA) Change From Baseline","description":"The primary endpoint evaluates the difference between treatment arms in change from baseline in coefficient of fat absorption (CFA). As such, descriptive statistics for individual treatment arms are not provided in this measure, but are reported in the secondary endpoints","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-11.852","spread":null}]}]}]},{"type":"SECONDARY","title":"Coefficient of Fat Absorption (CFA)","description":"Change from baseline in coefficient of fat absorption","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"76.5","spread":"16.13"},{"groupId":"OG001","value":"89.5","spread":"5.84"}]}]}]},{"type":"SECONDARY","title":"Coefficient of Nitrogen Absorption (CNA)","description":"Change from baseline in coefficient of nitrogen absorption","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"95.8","spread":"2.46"},{"groupId":"OG001","value":"97.5","spread":"1.21"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":7,"n":65},"commonTop":["Infective pulmonary exacerbation","Respiratory tract infection","Cough","Headache","Abnormal loss of weight"]}}}